Expert insights on IVD antibodies, immunoassay development, and diagnostic reagents from Sekbio's technical team
A landmark 2026 benchmark from Stanford and Harvard evaluates LLM agents on 100 real biomedical tasks. Key finding: agent architecture matters more than model choice — and all frontier models consistently fail at method selection and biological reasoning.
Sekbio exhibited at Medica 2025 in Düsseldorf, Germany, meeting IVD partners from 30+ countries. Visitors showed strong interest in our antibody stable cell line development service (94%+ success rate, <$1,000 transient screening) and validated OEM antibody pairs.
Deep dive into antigenic variation: from Trypanosoma brucei's coat switching to HIV's predictable escape pathways. Explore the molecular disguise mechanisms pathogens use to evade the immune system and how modern diagnostics catch them.
Comprehensive guide to Vitamin D detection using ELISA for routine IVD workflows. Learn about assay optimization, performance parameters, and troubleshooting tips for accurate 25-hydroxyvitamin D measurement.
Explore the development of rapid test kits for Nipah virus detection, including assay design challenges, sensitivity requirements, and implementation strategies for outbreak control.
Detailed overview of Cholera O1 antibodies, their applications in diagnostic assay development, and best practices for ensuring specificity and sensitivity in cholera detection systems.
Learn how Sekbio helped a diagnostic manufacturer achieve sub-pg/mL sensitivity for cardiac troponin I detection through advanced antibody engineering and assay optimization techniques.
Introducing our new IL-6 antibody pair with enhanced sensitivity for detecting cytokine levels in sepsis and COVID-19 patients. Performance data and application examples included.
WHO confirmed an Andes hantavirus cluster aboard the MS Hondius in May 2026. This technical guide covers hantavirus biology, the IgM/IgG diagnostic window, and a step-by-step strategy for developing serological assays — from N protein antigen selection to LFA and CLIA format design.
HRP2 gene deletions in P. falciparum are rendering standard malaria RDTs blind worldwide. Discover how GAPDH and DHFR-TS — essential, undeletable enzymes — are leading the race toward evolution-proof diagnostics.
Comprehensive guide to selecting optimal antibody pairs for sandwich immunoassays, covering epitope mapping, affinity considerations, and validation protocols for reliable assay performance.